230
Participants
Start Date
April 12, 2016
Primary Completion Date
December 31, 2017
Study Completion Date
December 31, 2017
Squalamine lactate ophthalmic solution, 0.2%
Squalamine lactate ophthalmic solution, 0.2%
Placebo Ophthalmic solution
Placebo Ophthalmic solution
ranibizumab
ranibizumab
Investigational Site, New York
Investigational Site, New York
Investigational Site, Great Neck
Investigational Site, Brooklyn
Investigational Site, Lynbrook
Investigational Site, Rockville Centre
Investigational Site, Hauppauge
Investigational Site, Syracuse
Investigational Site, Rochester
Investigational Site, Pittsburgh
Investigational Site, Camp Hill
Investigational Site, Lancaster
Investigational Site, Kingston
Investigational Site, Philadelphia
Investigational Site, Philadelphia
Investigational Site, Philadelphia
Investigational Site, Warrenton
Investigational Site, Rockville
Investigational Site, Glen Burnie
Investigational Site, Pikesville
Investigational Site, Baltimore
Investigational Site, Baltimore
Investigational Site, Hagerstown
Investigational Site, Fairfax
Investigational Site, Morgantown
Investigational Site, Concord
Investigational Site, Charlotte
Investigational Site, Columbia
Investigational Site, Mt. Pleasant
Investigational Site, Greenville
Investigational Site, Augusta
Investigational Site, Altamonte Springs
Investigational Site, Miami
Investigational Site, Miami
Investigational Site, Boynton Beach
Investigational Site, Fort Myers
Investigational Site, Naples
Investigational Site, Sarasota
Investigational Site, Stuart
Investigational Site, Mobile
Investigational Site, Nashville
Investigational Site, Kingsport
Investigational Site, Biloxi
Investigational Site, Louisville
Investigational Site, Paducah
Investigational Site, Toledo
Investigational Site, Cleveland
Investigational Site, Cleveland
Investigational Site, Cleveland
Investigational Site, Youngstown
Investigational Site, New Albany
Investigational Site, Royal Oak
Investigational Site, Detroit
Investigational Site, Southfield
Investigational Site, Jackson
Investigational Site, Grand Rapids
Investigational Site, Traverse City
Investigational Site, Madison
Investigational Site, Rapid City
Investigational Site, Sycamore
Investigational Site, Berwyn
Investigational Site, Chicago
Investigational Site, Bloomington
Investigational Site, Chesterfield
Investigational Site, Florissant
Investigational Site, Leawood
Investigational Site, Plano
Investigational Site, Grapevine
Investigational Site, Fort Worth
Investigational Site, Houston
Investigational Site, Kingwood
Investigational Site, The Woodlands
Investigational Site, Katy
Investigational Site, San Antonio
Investigational Site, McAllen
Investigational Site, Harlingen
Investigational Site, Salt Lake City
Investigational Site, Phoenix
Investigational Site, Phoenix
Investigational Site, Phoenix
Investigational Site, Tucson
Investigational Site, Henderson
Investigational Site, Las Vegas
Investigational Site, Los Angeles
Investigational Site, Beverly Hills
Investigational Site, Arcadia
Investigational Site, Sacramento
Investigational Site, Pasadena
Investigational Site, Glendale
Investigational Site, Glendora
Investigational Site, Oceanside
Investigational Site, Poway
Investigational Site, La Jolla
Investigational Site, Palm Desert
Investigational Site, Loma Linda
Investigational Site, Redlands
Investigational Site, Laguna Hills
Investigational Site, Fullerton
Investigational Site, Orange
Investigational Site, Palo Alto
Investigational Site, Campbell
Investigational Site, ‘Aiea
Investigational Site, Ashland
Investigational Site, Bellevue
Investigational Site, Spokane
Investigational Site, Bridgeport
Investigational Site, Hamden
Investigational Site, New London
Investigational Site, Portland
Investigational Site, Portsmouth
Investigational Site, Bloomfield
Investigational Site, Lawrenceville
Investigational Site, New Brunswick
Investigational Site, Northfield
Investigational Site, Ramsey
Investigational Site, Teaneck
Investigational Site, Toms River
Investigational Site, Burlington
Lead Sponsor
Ohr Pharmaceutical Inc.
INDUSTRY